Rheumatoid Arthritis

Cancer Risk Elevated in Patients With Immune-Mediated Inflammatory Disease

Physician’s Briefing

Cancer Risk Elevated in Patients With Immune-Mediated Inflammatory Disease

14 Apr 2026

2 min read

One Year of Abatacept Delays Progression to RA for Up to Four Years in At-Risk Population

Physician’s Briefing

One Year of Abatacept Delays Progression to RA for Up to Four Years in At-Risk Population

23 Jan 2026

2 min read

American College of Rheumatology, Oct. 24-29

Physician’s Briefing

American College of Rheumatology, Oct. 24-29

04 Nov 2025

3 min read

Read More

Clinical Briefing Report

clinicalbriefingreport.com